INVESTORS
Support translational research with potential financial upside.
Invest in institution-approved opportunities structured through compliant biotech investment vehicles such as SAFE notes or preferred equity.
Ideal for:
- Accredited investors
- Family offices
- Venture funds
- Impact investors
Key characteristics:
- Potential financial return
- Structured through compliant investment vehicles
- Milestone-based capital release
- Focus on translational and spinout opportunities
Donations are charitable contributions with no financial return. Investment opportunities are offered only to eligible investors and involve risk, including possible loss of principal.
